BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 31015105)

  • 1. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions.
    Banerjee K; Banerjee S; Mandal M
    J Colloid Interface Sci; 2017 Apr; 491():98-110. PubMed ID: 28012918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer.
    Jin X; Yang Q; Zhang Y
    Int J Nanomedicine; 2017; 12():5109-5118. PubMed ID: 28761344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo.
    Luput L; Sesarman A; Porfire A; Achim M; Muntean D; Casian T; Patras L; Rauca VF; Drotar DM; Stejerean I; Tomuta I; Vlase L; Dragos N; Toma VA; Licarete E; Banciu M
    Cancer Sci; 2020 Apr; 111(4):1344-1356. PubMed ID: 31960547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
    Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
    Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
    Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
    Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
    Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
    Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer.
    Gallant JN; Allen JE; Smith CD; Dicker DT; Wang W; Dolloff NG; Navaraj A; El-Deiry WS
    Cancer Biol Ther; 2011 Aug; 12(3):239-51. PubMed ID: 21725213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
    Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
    Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
    Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
    Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
    Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR
    Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29).
    Turktekin M; Konac E; Onen HI; Alp E; Yilmaz A; Menevse S
    J Med Food; 2011 Oct; 14(10):1107-17. PubMed ID: 21548803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
    Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S
    J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor model.
    Doi Y; Okada T; Matsumoto H; Ichihara M; Ishida T; Kiwada H
    Cancer Sci; 2010 Nov; 101(11):2470-5. PubMed ID: 20731663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
    Nakajima TE; Yasunaga M; Kano Y; Koizumi F; Kato K; Hamaguchi T; Yamada Y; Shirao K; Shimada Y; Matsumura Y
    Int J Cancer; 2008 May; 122(9):2148-53. PubMed ID: 18196580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.